Expression of STAT3 and SOCS3 in pancreatic acinar cells

Linda C Vona-Davis1, Krista A Frankenberry, Usman Waheed

  • 1Department of Surgery, West Virginia University, Morgantown, West Virginia 26506-9238, USA. lvdavis@hsc.wvu.edu

Abstract

Insights

Lipopolysaccharide (LPS) and tumor necrosis factor-alpha (TNFα) activate signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) pathways in pancreatic acinar cells. These findings suggest targeting the STAT pathway for pancreatic inflammation therapies.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Immunology

Background:

  • Signal transducer and activator of transcription (STAT) and suppressor of cytokine signaling 3 (SOCS3) pathways are implicated in organ inflammation.
  • The specific response of STAT3 and SOCS3 pathways to inflammatory stimuli in the pancreas remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of STAT3 and SOCS3 pathways in pancreatic acinar cells.
  • To determine if pro-inflammatory mediators like TNFα and lipopolysaccharide (LPS) induce mRNA expression of STAT3 and SOCS3.
  • To examine the influence of cytokines IL-1β and IL-6 on these pathways.

Main Methods:

  • Rat pancreatic acinar cells (AR42J) were treated with LPS or TNFα, alone or with IL-1β or IL-6.
  • Cells were analyzed for STAT3 and SOCS3 mRNA expression via RT-PCR at various time points (15–360 min).

Main Results:

  • LPS and TNFα significantly induced STAT3 and SOCS3 mRNA expression in pancreatic acinar cells.
  • IL-6 and IL-1β showed complex modulatory effects on SOCS3 expression, with some combinations enhancing and others reducing it.
  • Cytokines maintained elevated STAT3 mRNA levels when combined with TNFα.

Conclusions:

  • LPS and TNFα are potent inducers of STAT3 and SOCS3 expression in the pancreas.
  • IL-6 and IL-1β play an indirect role in the STAT signaling pathway within pancreatic acinar cells.
  • Modulating the STAT pathway presents a potential therapeutic strategy for pancreatic inflammation.